Secondary Logo

Journal Logo

Institutional members access full text with Ovid®


Dogra, Mohit, MS; Kumar, Ashok, MS; Bajgai, Priya, MS; Gupta, Vishali, MS; Bansal, Reema, MS; Dogra, Mangat R., MS; Vijayvergiya, Rajesh, MD; Singh, Ramandeep, MS

doi: 10.1097/IAE.0000000000002103
Original Study

Purpose: To evaluate the outcome of endovascular procedures on ocular findings in patients with Takayasu arteritis.

Methods: Retrospective study of patients who underwent percutaneous endovascular stenting of aortic arch arteries for Takayasu arteritis (TA) and who had documented retinopathy findings before and after the procedure. Change in visual acuity, regression of retinopathy, and development of complications after endovascular procedure were studied over a follow-up of 6 months.

Results: Ten eyes of five patients were included. Eyes which had Stage II or less of retinopathy before the endovascular procedure had favorable outcome; however, those with advanced stage of retinopathy at presentation had poor outcomes. Patients who underwent revascularization of both-sided arteries within 1 month had better anatomical and functional outcomes as compared with those who underwent sequential endovascular procedures on their arteries after a gap of 3 months or more.

Conclusion: Percutaneous endovascular stenting of aortic arch arteries, affected in TA, can lead to reversal of retinopathy changes and restoration of vision if done before neovascular complications set in.

Takayasu disease causes retinopathy in up to two-thirds of patients. Blinding neovascular complications are difficult to manage. Timely revascularization of affected aortic arch arteries through percutaneous endovascular stenting can reverse retinopathy changes and restore vision in these patients.

Advanced Eye Centre, Advanced Cardiac Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Reprint requests: Ramandeep Singh, MS, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, India-160012; e-mail:

None of the authors has any financial/conflicting interests to disclose.

M. Dogra and A. Kumar have contributed equally in the preparation of the manuscript.

© 2019 by Ophthalmic Communications Society, Inc.